Guangzhou LBP Medicine Science & Technology Co., Ltd.

SSE:688393.SS

28.33 (CNY) • At close June 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 72.543118.113124.61125.442101.469142.784143.553120.20990.745133.056131.8122.435120.09111.907114.706112.86899.508110.794119.819106.35838.462104.90494.34985.14970.758
Kosten van de omzet 27.5942.89744.21346.82528.28747.66149.47733.24926.28741.89237.48732.40134.9725.27127.33722.01822.32125.95721.21921.6497.13918.36214.16413.1812.237
Brutowinst 44.95375.21680.39778.61773.18295.12394.07586.96164.45891.16394.31490.03485.1286.63687.36990.8577.18784.83798.59984.7131.32386.54280.18571.96958.522
Brutowinstmarge 0.620.6370.6450.6270.7210.6660.6550.7230.710.6850.7160.7350.7090.7740.7620.8050.7760.7660.8230.7960.8140.8250.850.8450.827
Onderzoek- en ontwikkelingskosten 9.28414.3877.56712.4878.74118.08216.66815.09412.84320.28215.83516.46414.81310.87819.8059.1486.07210.2796.1897.0134.2528.3055.3114.7793.463
Algemene en administratieve kosten 17.557-61.17956.835-11.77121.65-40.76847.425-7.23118.626-33.34644.683-5.30914.422-6.83421.338-4.1448.55-10.91610.1351.6550.842-13.6095.8372.2280.929
Verkoop- en marketingkosten 37.38-28.93669.55351.6343.23257.07340.40846.29838.88453.29251.40945.80135.47349.12643.77548.42238.27156.48741.29143.60412.17455.16434.92641.60430.189
Verkoop-, algemene en administratieve kosten 54.937-90.115133.55668.56964.88216.30587.83239.06857.50919.94796.09240.49149.89542.29365.11344.27846.82145.57151.42645.25813.01641.55640.76343.83231.119
Overige kosten -4.809160.2090-0.022-0.276-0.71-2.454-1.794-1.96855.086-24.52224.460.183-0.4960.0870.241-0.0480.183-0.485-0.039-0.002-0.958-0.314-0.254-0.023
Bedrijfskosten 59.41285.66767.1981.07870.74593.59777.17681.28868.38495.31587.40581.41564.8986.91371.86365.86950.35266.95257.94457.33221.50168.66846.51254.65339.111
Bedrijfsresultaat -14.459-10.45113.207-2.4613.921-2.8817.2476.7370.408-10.5094.6719.24921.4264.29826.79226.54631.30420.96841.11927.3810.72917.88933.80618.38918.712
Bedrijfsresultaat ratio -0.199-0.0880.106-0.020.039-0.020.120.0560.004-0.0790.0350.0760.1780.0380.2340.2350.3150.1890.3430.2570.2790.1710.3580.2160.264
Totaal overige inkomsten en kosten netto -0.191-0.02-1.218-0.053-0.276-0.71-2.454-1.7940.2940.708-0.1634.157-0.44-0.4960.0870.241-0.0480.183-0.485-0.039-0.002-0.958-0.314-0.254-0.023
Inkomen voor belasting -14.65-10.47111.9894.4233.645-3.5914.7944.9430.702-9.8014.50813.09720.9873.80226.87926.78731.25621.1540.63427.34110.72716.93133.49218.13518.689
Inkomen voor belasting ratio -0.202-0.0890.0960.0350.036-0.0250.1030.0410.008-0.0740.0340.1070.1750.0340.2340.2370.3140.1910.3390.2570.2790.1610.3550.2130.264
Belastingkosten -2.4-2.1851.092-4.236-0.137-5.7780.4080.3330.868-5.1010.0520.8453.6650.9563.6473.8165.0223.1816.9954.3921.6633.5724.9492.883.043
Nettowinst -11.064-8.33913.2688.3737.9892.46319.4910.285-0.166-4.74.45612.25219.6245.26123.63424.21626.66518.3733.7822.7169.88113.74428.59915.93315.714
Nettowinstmarge -0.153-0.0710.1060.0670.0790.0170.1360.086-0.002-0.0350.0340.10.1630.0470.2060.2150.2680.1660.2820.2140.2570.1310.3030.1870.222
WPA (Winst Per Aandeel) -0.12-0.0890.140.090.090.0290.210.11-0.002-0.050.0480.130.210.0270.260.260.290.230.430.320.140.20.410.220.22
Verwaterde WPA -0.12-0.0850.140.090.080.0290.20.11-0.002-0.050.0480.130.210.0260.260.260.290.230.430.320.140.20.410.220.22
EBITDA -14.6040.88812.11317.02416.0059.67427.73416.84612.0842.61415.85922.58830.18511.65434.73229.95334.36221.1541.59829.01712.44217.87336.39520.2821.131
EBITDA ratio -0.2010.0080.0970.1360.1580.0680.1930.140.1330.020.120.1840.2510.1040.3030.2650.3450.1910.3470.2730.3240.170.3860.2380.299